Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.
Southeast Asian J Trop Med Public Health
;
2005 Mar; 36(2): 442-4
Article
Dans Anglais
| IMSEAR
| ID: sea-33714
ABSTRACT
The stools of 697 cases were examined by agar plate technique at Tambon Makam Luang, Sun Pa Tong district, Chiang Mai; there were Strongyloides stercoralis 15.9%,Opisthorchis viverrini 5.1%, intestinal fluke 0.1%. Treatment with ivermectin 78 cases and albendazole 33 cases of strongyloidiasis gave cure rates at 98.7% and 78.7%, respectively. Alkaline phosphatase in some patients were increased at mild level after treatment. Side effects in ivermectin group were anorexia, nausia, diarrhea, diffuse itching and drowsiness; and in albendazole group were nausia and diarrhea. The efficacy of single dose and mild side effects suggest ivermectin as drug of choice for strongyloidiasis treatment.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Strongyloides
/
Strongyloïdose
/
Thaïlande
/
Ivermectine
/
Femelle
/
Humains
/
Mâle
/
Albendazole
/
Prévalence
/
Répartition par sexe
Type d'étude:
Étude de prévalence
/
Facteurs de risque
Pays comme sujet:
Asie
langue:
Anglais
Texte intégral:
Southeast Asian J Trop Med Public Health
Année:
2005
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS